CLSI MM23
Molecular Diagnostic Methods for Solid Tumors (Nonhematological Neoplasms), 1st Edition, MM23Ed1E
standard by Clinical and Laboratory Standards Institute, 04/01/2015
CLSI H20-A2 (R2018)
Reference Leukocyte (WBC) Differential Count (Proportional) and Evaluation of Instrumental Methods; Approved Standard- Second Edition, H20-A2
standard by Clinical and Laboratory Standards Institute, 01/01/2007
CLSI AUTO16
Next-Generation In Vitro Diagnostic Instrument Interface, 1st Edition, AUTO16Ed1E
standard by Clinical and Laboratory Standards Institute, 04/23/2019
CLSI AUTO12-A (R2018)
Specimen Labels: Content and Location, Fonts, and Label Orientation; Approved Standard, AUTO12AE
standard by Clinical and Laboratory Standards Institute, 04/01/2011
CLSI M39-A4
Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline–Fourth Edition, M39A4E
standard by Clinical and Laboratory Standards Institute, 01/01/2014
CLSI NBS04
Newborn Screening by Tandem Mass Spectrometry, NBS04Ed2E
standard by Clinical and Laboratory Standards Institute, 05/01/2017
CLSI POCT17-Ed1
Use of Glucose Meters for Critically Ill Patients, 1st Edition, POCT17Ed1E
standard by Clinical and Laboratory Standards Institute, 03/29/2016
CLSI NBS05-A
Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AE
standard by Clinical and Laboratory Standards Institute,
CLSI M51-A (R2018)
Method for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi; Approved Guideline, M51A
standard by Clinical and Laboratory Standards Institute, 01/01/2010
CLSI NBS01-A6
Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard – Sixth Edition, NBS01A6E
standard by Clinical and Laboratory Standards Institute, 07/01/2013
CLSI H54-A (R2018)
Procedures for Validation of INR and Local Calibration of PT/INR Systems; Approved Guideline, H54-A
standard by Clinical and Laboratory Standards Institute, 08/19/2005